NervGen Pharma Corp
XTSX:NGEN
NervGen Pharma Corp
XTSX:NGEN
Price:
5.89
CAD
8.87%
Market Closed
Market Cap:
CA$473.5m
Balance Sheet
Balance Sheet Decomposition
NervGen Pharma Corp
NervGen Pharma Corp
Balance Sheet Decomposition is not available for
NervGen Pharma Corp
NervGen Pharma Corp
Balance Sheet
NervGen Pharma Corp
NervGen Pharma Corp
Currency: CAD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
2
|
4
|
6
|
17
|
22
|
|
| Cash |
0
|
2
|
4
|
6
|
17
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
22
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
1
|
0
|
1
|
|
| Total Current Assets |
0
|
3
|
6
|
6
|
17
|
23
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
3
+3 618%
|
7
+118%
|
7
-1%
|
18
+168%
|
24
+33%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
0
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
7
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+513%
|
1
+58%
|
1
-18%
|
1
+43%
|
10
+866%
|
|
| Equity | |||||||
| Common Stock |
0
|
4
|
15
|
23
|
42
|
57
|
|
| Retained Earnings |
0
|
1
|
9
|
17
|
26
|
44
|
|
| Total Equity |
0
N/A
|
3
N/A
|
6
+132%
|
6
+1%
|
17
+184%
|
13
-20%
|
|
| Total Liabilities & Equity |
0
N/A
|
3
+3 618%
|
7
+118%
|
7
-1%
|
18
+168%
|
24
+33%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
27
|
27
|
29
|
35
|
46
|
59
|
|
Switch to:
Switch to:
See Also
Discover More
